What is Fitvia Corp?
engages in the writing of patents.
BRZV · Verdict
Moderate reward · moderate risk
BRZV stands out on volatility and balance sheet, but watch the cash flow signal.
Based on 88% data coverage
BRZV · Verdict
Top decile vs peers
Current ratio 0.02
Weak vs peers
0% return on equity
Earnings +19.5% CAGR
Model-based scoring. For information only — not financial advice.
engages in the writing of patents. The company is also involved in writing business plans for small, medium, and large companies. The company is listed on the PINK in USA, operating in the Consumer Defensive sector, with a market capitalisation of 467.69K.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.